Want to see GB:STX full AI Analyst Report?

Shield Therapeutics (STX) Revenue

42 Followers

Shield Therapeutics Revenue

Shield Therapeutics had a revenue of 30.12M in the quarter ending Jun 30, 2026, with 6.10%. This bring the company's revenue in the last twelve months to 58.51M, Decreased 14.57%. In the fiscal year ending Mar 31, 2026, Shield Therapeutics had annual revenue of 50.74M with 57.69% growth.

Revenue (ttm)

58.51M

Revenue Growth

36.19%

P/S Ratio

0.99

Revenue/Employee

£831,865

Employees

Market Cap

£50.29M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	50.74M	18.56M	+57.69%
Dec 31, 2024	32.18M	15.64M	+94.57%
Dec 31, 2023	16.54M	12.06M	+268.96%
Dec 31, 2022	4.48M	2.96M	+195.11%
Jun 30, 2022	1.52M	-8.87M	-85.38%
Dec 31, 2020	10.39M	9.67M	+1,344.65%
Dec 31, 2019	719.00K	-11.16M	-93.95%
Dec 31, 2018	11.88M	11.24M	+1,765.15%
Dec 31, 2017	637.00K	―	―